This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB03641/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB03641/identifier/pubchem-compound/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://linked.opendata.cz/resource/drugbank/drug/DB03641/identifier/pubchem-substance/
owlhttp://www.w3.org/2002/07/owl#
n4http://linked.opendata.cz/ontology/drugbank/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03641/identifier/drugbank/
n5http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03641
rdf:type
n4:Drug
n4:group
experimental
owl:sameAs
n7:DB03641 n8:DB03641
dcterms:title
2'-deoxyuridine 5'-alpha,beta-imido-diphosphate
adms:identifier
n10:46936740 n11:46506709 n12:DB03641 n13:DUN
n4:synonym
2,4(1h,3h)-pyrimidinedione, 1-[2-deoxy-5-o-[hydroxy(phosphonoamino)phosphinyl]-beta-d-erythro-pentofuranosyl]-
n4:IUPAC-Name
n5:271B5B9A-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B5BA0-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B5B9F-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B5B9C-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B5B9D-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B5B9E-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B5B98-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B5B99-363D-11E5-9242-09173F13E4C5 n5:271B5B96-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B5B97-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B5BA6-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B5BA7-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B5BA1-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B5BA2-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B5BA4-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B5BA3-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B5BA5-363D-11E5-9242-09173F13E4C5
n4:Bioavailability
n5:271B5BAC-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B5BAE-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B5BAF-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B5BAB-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B5BAA-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B5BAD-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B5B9B-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B5BA8-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B5BA9-363D-11E5-9242-09173F13E4C5